Research Site

Nehrar 37024

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer — Running, not enrolling